|
|||||||||
|
|
|
|
|
|
|
|
|
|
|
Blood, 1 May 2007, Vol. 109, No. 9, pp. 3794-3802. Prepublished online as a Blood First Edition Paper on January 3, 2007; DOI 10.1182/blood-2005-09-010116.
IMMUNOBIOLOGY An essential role for IL-17 in preventing pathogen-initiated bone destruction: recruitment of neutrophils to inflamed bone requires IL-17 receptor–dependent signals1 Department of Microbiology and Immunology, School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York (SUNY), Buffalo, NY; 2 Department of Oral Biology, School of Dental Medicine, University at Buffalo, SUNY, Buffalo NY; 3 Department of Biology, Bates College, Lewiston ME; 4 Department of Pediatrics, David Geffen School of Medicine and Mattel Children's Hospital at University of California at Los Angeles, Los Angeles, CA
IL-17 and its receptor are founding members of a novel family of inflammatory cytokines. IL-17 plays a pathogenic role in rheumatoid arthritis (RA)–associated bone destruction. However, IL-17 is also an important regulator of host defense through granulopoiesis and neutrophil trafficking. Therefore, the role of IL-17 in pathogen-initiated bone loss was not obvious. The most common form of infection-induced bone destruction occurs in periodontal disease (PD). In addition to causing significant morbidity, PD is a risk factor for atherosclerotic heart disease and chronic obstructive pulmonary disease (COPD). Similar to RA, bone destruction in PD is caused by the immune response. However, neutrophils provide critical antimicrobial defense against periodontal organisms. Since IL-17 is bone destructive in RA but a key regulator of neutrophils, we examined its role in inflammatory bone loss induced by the oral pathogen Porphyromonas gingivalis in IL-17RA–deficient mice. These mice showed enhanced periodontal bone destruction, suggesting a bone-protective role for IL-17, reminiscent of a neutrophil deficiency. Although IL-17RA–deficient neutrophils functioned normally ex vivo, IL-17RA knock-out (IL-17RAKO) mice exhibited reduced serum chemokine levels and concomitantly reduced neutrophil migration to bone. Consistently, CXCR2KO mice were highly susceptible to alveolar bone loss; interestingly, these mice also suggested a role for chemokines in maintaining normal bone homeostasis. These results indicate a nonredundant role for IL-17 in mediating host defense via neutrophil mobilization.
The IL-17 cytokine family consists of 6 cytokines (IL-17A to IL-17F) and at least 5 receptors (IL-17RA to IL-17RE; reviewed in Moseley et al1). The IL-17 superfamily bears little sequence homology to other cytokine families, and its in vivo functions and molecular biology are poorly understood. Like many inflammatory cytokines, IL-17 plays both protective and pathogenic roles in the immune system. On one hand, IL-17 is important for host defense against infectious organisms, including Klebsiella pneumoniae, Candida albicans, and Toxoplasma gondii.2–4 Conversely, elevated levels of IL-17 are found in autoimmune diseases, including rheumatoid arthritis (RA)/collagen-induced arthritis (CIA), colitis, and multiple sclerosis/experimental autoimmune encephalomyelitis (EAE).5,6 IL-17 was recently shown to be the hallmark cytokine produced by a newly-identified subset of T helper cells, called "Th17," which are generated following signals from TGFß, IL-6, and IL-23.7 Although produced primarily by T cells, IL-17 activates many of the same signaling events as innate cytokines such as TNF  and IL-1ß, and is thus considered an important bridging molecule between the adaptive and innate immune systems.8,9
IL-17 plays a particularly significant role in regulating neutrophil recruitment and granulopoiesis.10–12 IL-17 up-regulates granulocyte colony-stimulating factor (G-CSF), and overexpression of IL-17 causes neutrophilia in mice.13 In addition, the most strongly induced IL-17 target genes are neutrophil-recruiting chemokines, such as Gro Considerable evidence shows that IL-17 impacts bone turnover, particularly in inflammatory arthritis.20 IL-17 is elevated in RA synovial fluid and exerts direct effects on bone cells.6,21 Blocking IL-17 in rodent models of arthritis reduces inflammation and bone damage, whereas excess IL-17 exacerbates disease.22–25 Furthermore, IL-17 knock-out (KO) mice are resistant to CIA, and other mouse models also resistant to CIA show defects in IL-17 production.26,27 Therefore, IL-17 and its receptor are considered attractive therapeutic targets for inflammatory diseases.28 The paradoxical functions of IL-17 raised the question of its role pathogen-induced inflammatory bone loss. Periodontal disease (PD) accounts for most bone disease in humans, and causes tooth loss in 15% of adults.29 Over 75% of the population experiences some form of PD, with significant economic and medical consequences. Not only does PD cause substantial morbidity in its own right, but it is a risk factor for life-threatening conditions such as cardiovascular disease, diabetes, and chronic obstructive pulmonary disease (COPD).30,31 The process of tooth loss is initiated by a subgingival infection that destroys underlying alveolar bone as well as the connective tissue attachment between the gingiva and tooth root. Several Gram-negative bacterial species are associated with periodontal bone loss.32–34 These bacteria initiate but do not directly cause bone destruction in PD. Although periodontal pathogens express a variety of tissue-eroding virulence factors, most damage is actually a result of host response mechanisms.35,36 Neutrophils, however, play a key role in defense against periodontal infection. Indeed, humans with defects in neutrophil adhesion or trafficking are highly susceptible to PD, and frequently lose all their teeth before adulthood.34,35 Thus, the role of IL-17 in periodontal disease was not obvious. While IL-17 has been implicated in a few of studies of severe PD,37,38 its role in this disease remains largely undefined. Whereas IL-17 is clearly bone destructive in the context of arthritis, its potent effects on neutrophils suggested that IL-17 could play a defensive role in PD, ultimately exerting a net bone-protective effect (Figure 6). Accordingly, we used IL-17RA–deficient mice to determine the role of IL-17 signaling in a murine model of Porphyromonas gingivalis–induced alveolar (jaw) bone loss. Our results indicate that the overall influence of IL-17 is bone protective in this setting, largely through control of chemokine expression and neutrophil recruitment. Thus, the positive influence of IL-17 on neutrophil regulation outweighs its potential bone-destructive signals, underscoring the importance of IL-17–mediated control of neutrophil mobilization in vivo.
Mice IL-17RAKO mice were generously provided by Dr J. Kolls (University of Pittsburgh, PA) with permission from Amgen (Seattle, WA), and CXCR2KO and wild-type (WT) mice (C57BL/6 and BALB/C) were from The Jackson Laboratory (Bar Harbor, ME). Genotypes were confirmed by polymerase chain reaction (PCR). Mice were maintained in HEPA-filtered cages with autoclaved food, water, and bedding. Animals within an experiment were age- and strain-matched females (4-8 mice per group), 6 to 7 weeks old. All procedures were performed in accordance with protocols approved by the University at Buffalo Institutional Animal Care and Use Committee (IACUC). Bacterial culture P gingivalis (A7A1-28) was stored in defibrinated sheep blood (Crane Laboratories, Syracuse, NY) at –70°C. Bacteria were maintained by weekly transfer on supplemented blood agar (Brain Heart Infusion Agar [BD Biosciences, San Jose, CA] with 5.0 µg/mL hemin, 5.0 µg/mL menadione [Sigma, St Louis, MO], and 5% defibrinated sheep blood), and grown anaerobically under 5% CO2, 5% H2, and 90% N2 at 37°C. Oral infections and bone loss assessment Mice were infected as described.39 Briefly, to reduce oral flora, animals were given sulfamethoxazole trimethoprim in 10 mL/L drinking water (2 mg/mL wt/vol and 0.4 mg/mL wt/vol, respectively) for 10 days, followed by a 5-day wash-out. Infected groups were given 109 CFU Pg suspended in 500 µL PBS with 2% carboxymethylcellulose (CMC; Sigma) via feeding needle 3 times at 2-day intervals. The dosage used was 250 µL placed in the throat and 250µL placed directly in the oral cavity. Control groups were given CMC alone on the same schedule. Forty-two days after the third inoculation, serum was collected by cardiac puncture. Jaws were autoclaved and defleshed, immersed overnight in 3% hydrogen peroxide, and stained with 1% methylene blue in PBS. Horizontal bone loss was assessed morphometrically by measuring the distance between the cementoenamel junction (CEJ) and the alveolar bone crest (ABC). Measurements at 14 buccal sites per mouse (7 sites on the left and right maxillary molars) were made under a dissecting microscope (Brook-Anco, Rochester, NY) fitted with an Aquinto imaging measurement system (a4i America). Random and blinded bone measurements were taken by 2 independent evaluators. All data were analyzed on GraphPad Prism 4 software (GraphPad, San Diego, CA).
For in situ neutrophil recruitment assays, gauze strips soaked in a chemoattractant mixture (100 µg/mL Gro ELISA
Pg-specific enzyme-linked immunosorbent assays (ELISAs) were performed as described.39 Briefly, polystyrene plates were coated with formalin-killed Pg. Serial dilutions (2-fold) of test or positive control sera (22 to 212) were incubated for 1 hour at 37°C and washed. Alkaline phosphatase–conjugated goat anti-mouse IgM, IgA, or IgG Abs (Zymed Laboratories, South San Francisco, CA) were used to detect bound Ab, which was quantified by P-nitrophenyl phosphate substrate and absorbance at OD405. Titer was defined as the reciprocal of the highest dilution that produced OD readings more than 0.1 OD unit above background. Total IgG was determined using a mouse IgG quantitation kit (Bethyl Laboratories, Montgomery, TX). Gro Cell culture and neutrophil migration assays
MC3T3-E1 cells were cultured in Flow cytometry Bone marrow cells (106) from 8- to 12-week-old female WT or IL-17RAKO mice were stained with 1 µg anti-mouse CXCR2 (clone 242216; R&D Systems) and FITC-conjugated anti-rat IgG2a (clone RG7/1.30; BD Pharmingen) and 0.1 µg anti–Gr-1–PE (clone RB6-8C5; BD Pharmingen). Cells were analyzed using a FACScalibur and CellQuest software (BD Biosciences). Histology and immunohistochemistry Maxillary tissue was harvested 24 hours after the first or third infections in 2 mice per group. Tissue was fixed overnight in 10% neutral buffered formalin, decalcified in CalEx II (Fisher Scientific, Pittsburgh, PA) for 72 hours, and dehydrated in 20% ethanol for 1 hour, 50% ethanol for 1 hour, and 70% ethanol for 1 hour. Samples were embedded in paraffin and serially sliced into 0.2-µm sagittal sections, and stained in hematoxylin and eosin by the University at Buffalo Histology Services Core Facility. Sections were analyzed under oil emersion at x 1000 magnification. Positive identification of tissue neutrophils was determined by matching nuclear morphology and cytoplasmic color to previously identified neutrophils in a neighboring capillary, and observations were verified by an oral pathologist. Total neutrophils present in capillaries, gingival epithelium and connective tissue proximal to molars was determined in 40 sequential sections per mouse, excluding sections without teeth. Neutrophils were normalized to the number of teeth in the section.
For immunohistochemistry, Abs were generated against mouse LIX in rabbits by Cocalico Biological (Reamstown, PA) using a synthetic 92-residue peptide corresponding to the full-length LIX.40 The peptide was synthesized at the Microchemical Core Facility of the Norris Comprehensive Cancer Center (University of Southern California, Los Angeles, CA), and purified by high-performance liquid chromatography (HPLC). Peptide composition was verified by mass spectrometry and amino acid analysis. Cross-reactivity to Gro
IL-17RAKO mice show enhanced susceptibility to alveolar bone loss following Pg infection To date, no studies have examined a role for IL-17 or its receptor in bone loss triggered by infection. Since IL-17 is produced by activated T cells and promotes the production of IL-6 and other inflammatory mediators, there were many reasons to think that this cytokine may contribute to bone destruction.37,38,41 However, IL-17 also regulates chemokine expression and neutrophil recruitment (reviewed in Linden and Adachi10), which correlates strongly with alveolar (jaw) bone protection in PD.42,43 Therefore, we addressed the role of IL-17 signaling in a widely-accepted PD bone loss model using IL-17R–deficient (IL-17RAKO) mice3 infected with the human periodontal pathogen P gingivalis (Pg). Importantly, IL-17RAKO mice do not exhibit obvious bone defects such as runting or incomplete tooth eruption (data not shown). To determine whether IL-17RAKO mice showed altered resistance to bone loss following Pg infection, IL-17RAKO and age-matched C57BL/6 WT mice were infected orally with Pg suspended in carboxymethylcellulose (CMC). Parallel groups of WT and IL-17RAKO mice were sham-infected with CMC alone. Importantly, infection did not cause significant weight changes or other unexpected side effects (data not shown). In this model, statistically significant bone destruction levels off at approximately 6 weeks after infection.44 Therefore, alveolar bone loss was assessed after 6 weeks at 14 buccal sites per mouse. Horizontal alveolar bone loss was quantified by measuring the distance between the cementoenamel junction (CEJ) and the alveolar bone crest (ABC) (Figure 1). C57Bl/6 mice are known to be resistant to bone destruction induced by Pg,45,46 so it was not surprising that no significant differences in ABC/CEJ distances were observed between sham-infected and Pg-infected WT animals (Figure 1A). In contrast, IL-17RAKO mice showed significant bone loss at multiple sites (ranging from 29%-57%), particularly in the vicinity of the first molar (Figure 1B-D; sites 1-3). Although the magnitude of alveolar bone loss in this model varies by strain and sex, it is typical to observe a 20% to 50% increase in ABC/CEJ distances,41 and therefore these results indicate considerable bone destruction. Thus, the absence of signaling through IL-17RA predisposes mice to bone loss following periodontal infection.
Infection was confirmed by demonstrating that Pg could be recovered by paper point assay and PCR of Pg 16S ribosomal DNA in both WT and IL-17RAKO mice (data not shown). We examined Pg-specific antibody titers to assess immune responses to the bacteria. Consistent with other studies, Pg-specific IgA was too low to be detected, and no changes in Pg-specific IgM were observed (data not shown).39 However, levels of anti-Pg IgG were strongly enhanced following Pg infection in both WT and IL-17RAKO mice (Figure 2A). While all IgG isotypes were enhanced following Pg infection, only IgG2b was elevated disproportionately in IL-17RAKO mice (data not shown). Interestingly, the baseline levels of IgG were considerably higher in sham-infected IL-17RAKO mice compared with sham-infected WT mice. Since these mice were never exposed to Pg (nor was Pg recovered from sham-infected mice; data not shown), we hypothesized that this result might be due to an elevation in overall levels of IgG in IL-17RAKO mice, causing a higher nonspecific background signal. Indeed, total IgG levels were enhanced 1.6-fold in IL-17RAKO mice compared with WT (Figure 2B). Thus, although baseline IgG levels differed between WT and IL-17RAKO mice, both strains mounted vigorous anti-Pg responses after infection.
IL-17RAKO neutrophils
The enhanced susceptibility to bone loss observed in IL-17RAKO mice was reminiscent of findings in other strains with defects in neutrophil recruitment (eg, ICAM-1KO and P/E-selectinKO mice).35,42,43 Since IL-17 has been strongly implicated in neutrophil activity,3,19 we hypothesized that neutrophils in IL-17RAKO mice were functioning abnormally. To determine whether this defect was an intrinsic property of IL-17RAKO neutrophils, we assessed their migratory capacity compared with that of WT. As a source of chemoattractants, we used the bacterial peptide fMLP or conditioned media from a preosteoblast cell line (MC3T3-E1) known to produce high amounts of CXC chemokines (LIX and Gro
Since neutrophils in IL-17RAKO mice exhibited a normal ability to migrate to exogenous chemokines both ex vivo and in vivo, we next determined whether neutrophils migrated efficiently to the site of Pg infection in IL-17RAKO mice. Despite widespread use of this model, no one to our knowledge has ever directly quantified neutrophil recruitment to mouse gingiva following periodontal infection. To assess kinetics of neutrophil recruitment, IL-17RAKO and age-matched WT mice were sham- or Pg-infected 3 times over 5 days. Mice were killed 24 hours after either the first or third inoculations, and maxillary jaw tissue was harvested and decalcified for histologic analysis. No abnormalities in the morphology of teeth or alveolar bone were observed in IL-17RAKO mice, either in baseline (sham) or Pg-infected conditions (Figure 4B-C; data not shown). To quantify neutrophils in tissue adjacent to the gingival sulcus, we counted hematoxylin and eosin (H&E)–stained polymorphonuclear cells in 60 to 80 serial histologic sections per mouse (2 mice per group). Very little neutrophil recruitment to gingival tissue was observed in WT or IL-17RAKO mice 24 hours after the first infection (data not shown). However, as expected, the number of neutrophils found in situ in Pg-infected WT mice increased significantly relative to sham-treated WT mice 24 hours after the third inoculation (Figure 4A). In these mice, neutrophils could readily be observed in capillaries as well as adjacent connective tissue and epithelium, as would be expected in an inflamed environment. Strikingly, however, the number of neutrophils infiltrating the gingiva in Pg-infected IL-17RAKO mice was not significantly different from sham-treated mice, and few neutrophils were found in connective or epithelial tissue (Figure 4C). Therefore, IL-17RAKO mice mount a markedly reduced neutrophil response at the site of gingival infection.
Decreased chemokine expression in IL-17RAKO mice
Collectively, these data support a model whereby the enhanced bone loss observed in IL-17RAKO mice is a result of defective neutrophil migration to the site of infection in alveolar bone. Chemokines, particularly those involved in neutrophil recruitment such as LIX and Gro
To further confirm the central role of CXC chemokines in protecting against PD bone destruction, we examined the consequence of a chemokine deficiency using CXCR2KO mice.47 CXCR2 binds the IL-17–induced chemokines Gro , LIX, and MIP2. Neutrophils from these mice exhibit normal killing activity but dramatically impaired migration.47 Interestingly, the alveolar bone in the CXCR2KO mice was very fragile even in an unchallenged state, with extremely large ABC/CEJ distances at most sites and a rough alveolar bone crest (Figure 5B-C). Since the mice were housed in specific pathogen–free (SPF) conditions, this observation may indicate a role for CXCR2 in maintaining normal bone homeostasis, which is consistent with their runted phenotype (data not shown). However, ABC/CEJ distances increased even further following Pg infection, and in some mice resulted in a loss of dentition (data not shown; Figure 5B). Because the CXCR2KO mice are on the BALB/C background, the WT control mice experienced detectable bone loss (Figure 5B), and the susceptible buccal sites of bone loss were somewhat different from the IL-17RAKO mice, which are on the C57BL/6 background (Figure 1 vs Figure 5). However, IL-17RAKO mice backcrossed to BALB/C show a similar increase in Pg-induced alveolar bone destruction (data not shown), indicating that IL-17 contributes to bone loss regardless of genetic background. These data show that a CXC chemokine deficiency shows an even more severe phenotype with respect to oral bone loss than the IL-17RA deficiency, and supports a model whereby chemokines and neutrophils are essential to protect alveolar bone.
The cellular source(s) of chemokines in the setting of PD infection is not known. To determine which cells were expressing neutrophil-attractive chemokines, we performed immunohistochemistry on oral tissue from Pg-infected WT mice, staining with antisera that recognizes the 3 major neutrophil-recruiting CXC chemokines, LIX, Gro
The immune system is regulated by myriad multifaceted interactions, and perhaps the most challenging to decipher has been the extraordinarily complex network of functions mediated by cytokines. While studies of cytokines in cultured cells have been enlightening, only studies in vivo reveal their activities in complex immunologic environments. Indeed, studies of cytokines in animal models have frequently yielded unexpected results that have generated important insights into cytokine biology.48
The IL-17 family is particularly fascinating because of its many novel properties.1 Structurally, IL-17 and its receptor bear little resemblance to other well-described cytokine families.49 In culture systems, IL-17 behaves much like classic inflammatory cytokines such as TNF
Studies in humans and animal models have confirmed that IL-17 plays a pathogenic, bone-destructive role in RA (reviewed in Gaffen25 and Lubberts and Koenders28). Many IL-17 target genes impact bone destruction, either through triggering osteoclastogenesis directly or driving up-regulation of genes in osteoblasts that in turn drive osteoclastogenesis (Figure 6; Kotake et al6 and Sato et al20). IL-17 also synergizes potently with TNF
By far the most common form of human bone loss occurs in PD.35 PD is a risk factor for atherosclerotic heart disease, COPD, diabetes, increased preterm labor, and low birth weight.30,31 The immune system contributes to bone loss in many disease conditions, and T cells play a particularly key role in periodontal bone erosion.58,59 This is largely due to the ability of T and B cells to up-regulate RANKL, a key maturation factor for bone-erosive osteoclasts.36,60 Consistently, severe combined immunodeficient (SCID) mice and mice deficient in CD4+ T cells are resistant to Pg-induced bone destruction.39,41 Likewise, cytokines derived from T cells and innate cells play important roles in the etiology of PD. IL-1ß, in particular, has a strong association with susceptibility to PD,61 probably in part due to its ability to enhance osteoclastogenesis by regulating RANKL expression on osteoblasts. Therefore, T cells and inflammatory cytokines drive alveolar bone destruction and the tooth loss that results. IL-17 is derived from T cells and clearly has bone-destructive effects in RA. However, we observed that IL-17 signaling through IL-17RA exerts a profound bone-protective effect on PD bone loss. This was not entirely unexpected, since recent work has elucidated a key role for IL-17 in regulating neutrophils in vivo,11 and neutrophils play a well-characterized and essential function in controlling periodontal infection. Humans with inherited disorders in neutrophil chemotaxis have a high frequency of early-onset periodontitis (eg, localized aggressive periodontitis), and genetic polymorphisms affecting chemokine expression have been linked to susceptibility to PD.34 Since neutrophils serve as a first line of defense against infection, the consequence of reduced neutrophil activation is increased bacterial load. Thus, in a sterile inflammatory state such as RA or other autoimmune diseases, IL-17 signaling contributes to tissue damage,62 whereas in bacterial infections such as PD, IL-17 may be critical for recruiting neutrophils and/or other immune cells required to limit the spread of infection. Similar dual roles for other so-called "inflammatory" cytokines have been found in numerous diseases.48 Accordingly, it would be predicted that bacterial load is elevated in IL-17RAKO mice. However, in the PD model used here, it is extremely difficult to quantify accurately the amount of Pg present in gingiva. Although Pg can be recovered from subgingival areas by paper point, recovery is not quantitative or reproducible.63–65 Comparisons to other cultivable flora are sometimes used to normalize Pg levels,66 but this is not an appropriate control in immunocompromised IL-17RAKO mice, which likely have an overall increase in oral microbial burden. Similarly, it is not feasible to normalize Pg to gingival crevicular fluid, as volumes in mice are too small to be measured. Indeed, even in humans, precise quantitation of Pg is considered very challenging, although PCR-based methods have been attempted.67,68 Using PCR to assess levels of Pg 16S ribosomal DNA, we did not find detectable differences in Pg load in WT versus IL-17RAKO mice (data not shown). Thus, we found no evidence to support the hypothesis that bacterial load is increased in IL-17RAKO mice, although the limitations of the available assays still do not rule this out. Therefore, it is quite possible that increases in Pg in IL-17RAKO mice are subtle or nonexistent, and that enhancement of inflammation due to elevated bacterial burden is not the primary explanation for the enhanced bone loss observed here. Why then, would an imbalance in chemokines and neutrophil migration caused by an IL-17 deficiency lead to enhanced bone loss? Much recent literature has demonstrated a complex relationship between chemokines, neutrophils, and lymphocyte homeostasis,19,69 and that a reciprocal relationship between neutrophils and lymphocytes appears to exist during inflammatory processes.70,71 Therefore, it is plausible that the reduction in chemokines and neutrophils observed in IL-17RAKO mice following infection disrupts the overall balance of immune responses in these mice, leading to enhanced lymphopoiesis, which in turn causes exacerbated bone turnover. Also consistent with this idea is that B-cell homeostasis is dysregulated in CXCR2KO mice.47 It is well established that periodontal bone loss is driven by the immune system,35 which occurs by overexpression of RANKL on activated T and B lymphocytes.36 RANKL is critical for driving development of osteoclasts, a monocyte-derived cell lineage that promotes bone destruction.60 It has been demonstrated in both RA and PD that lymphocyte expression of RANKL is responsible for immune-mediated bone turnover.36,72 Once the inflammation process is initiated by Pg, the immune-dependent bone loss can proceed independently of antigen. Therefore, enhanced bone loss in IL-17RAKO mice may occur not directly because of increased bacterial load, but rather because of dysregulated lymphopoiesis that follows the initial infection. A few clinical reports suggest a pathogenic role for IL-17 in severe PD.37,38 Human PD is a complex disease state characterized by multiple microbial agents and influenced by a variety of host-dependent factors. The monoinfection system used here is considered to be a model of acute rather than chronic PD, so it is possible that in chronic phases of long-term inflammation, IL-17 may "switch sides" to play a pathogenic rather than protective role.48 Consistent with this, neutrophils are thought to be bone destructive in long-term chronic inflammation, both in RA and PD.62,73,74 Thus, while blockade of IL-17 may be beneficial in autoimmunity, targeting IL-17 may have undesired consequences such as causing increased susceptibility to otherwise mild diseases such as PD.
Our results indicate that the defect in IL-17RAKO mice lies in the ability of neutrophils to reach the gingiva (Figures 3
It is striking that a lack of IL-17RA exerts such a profound effect on neutrophil recruitment, since other cytokines still present in these mice also regulate expression of chemokines and other genes involved in neutrophil activation (eg, TNF
While chemokine expression and neutrophil migration is impaired in IL-17RAKO mice, there may be defects in other arms of the immune system as well. In examining humoral responses, we made the unexpected finding that total levels of IgG are considerably elevated in IL-17RAKO mice (Figure 2). While the mechanistic basis for this difference remains unknown, a similar phenomenon has been observed in other KO mouse strains, and could be due to changes in IgG processing or FcR
As with many rodent disease models, alveolar bone loss is influenced by genetic background. The IL-17RAKO mice were created on the C57BL/6 strain, which shows a natural resistance to Pg-induced bone destruction.45,66 Studies comparing gene expression in gingiva and spleens of susceptible (Balb/cByJ) versus Pg-resistant (A/J) mice showed that IL-1ß, TNF In summary, IL-17 is an intriguing new cytokine with important host defense functions in vivo. Although considerable literature has implicated IL-17 in bone erosion in RA, this cytokine plays a dominantly protective role in bone loss following periodontal infection. These findings have important implications for the use of pharmacologic blockers of IL-17, as well as defining the in vivo biology of this cytokine.
Author contributions: J.J.R., M.J.R., G.C.W., and C.S. performed experiments; J.J.R., M.J.R., and S.L.G. designed experiments; P.J.B., R.T.E., and C.S. trained personnel in infection procedures and advised on model; J.B.S. provided key reagents and advice; and S.L.G. wrote the paper with input from M.J.R. and J.J.Y. Conflict-of-interest statement: The authors declare no competing financial interests. Correspondence: Sarah L. Gaffen, 36 Foster Hall, 3435 Main St, Buffalo, NY 14214; e-mail: sgaffen{at}buffalo.edu.
We thank Drs J. Tocker, J. Peschon, S. Levin, K. Kirkwood, A. Teng, R. Genco, E. Hausman, A. Sharma, X. Lin, S. Gollnick, M. Taubman, P. Stashenko, and L. Garrett-Sinha for helpful suggestions and critical comments. IL-17RAKO mice were generously provided by Dr J. Kolls with permission from Amgen. We are especially grateful to Dr M. Neiders for help with histologic analyses and Dr M. Cho for assistance with in situ neutrophil recruitment studies. We thank S. Printup Jacobs and K. Pufpaff for technical assistance. S.L.G. was supported by National Institutes of Health (NIH) grants AI49329 and AR050458. P.J.B. was supported by NIH grant DE10728. J.J.Y. was supported by a University at Buffalo (UB) Oral Biology training grant DE007034 and the Medical Scientist Training Program at UB. M.J.R. was supported by a training grant to the UB Witebsky Center for Microbial Pathogenesis and Immunology (AI07614). J.B.S. was supported by NIH grant HL57008. R.T.E. was supported by an Oral Immunity grant administered by the Department of Oral Biology at SUNY Buffalo and Therex, LLC (Buffalo, NY).
Submitted September 28, 2005; accepted December 25, 2006.
Prepublished online as Blood First Edition Paper, January 3, 2007
DOI: 10.1182/blood-2005-09-010116
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Top
Abstract
Introduction
) and IL-17RAKO (
) mice by ELISA.
significant difference between WT and IL-17RAKO mice for the same treatment condition (P < .01). (B) Normal CXCR2 levels in IL-17RAKO mice. Bone marrow from WT (black) or IL-17RAKO (gray) mice was stained with Abs to Gr1 and CXCR2. Cells were gated on the Gr1+ population, and the profile of CXCR2 staining is shown compared with the isotype control. (C) Ectopically applied chemokines rescue neutrophil migration to gingiva in IL-17RAKO mice. WT and IL-17RAKO mice were anesthetized, and a mixture of LIX and Gro
expression.